Home » Seattle Genetics Leads Roche in Race to Develop Cancer Combo
Seattle Genetics Leads Roche in Race to Develop Cancer Combo
Seattle Genetics Inc. and Takeda Pharmaceutical Co. may beat Roche Holding AG in developing a new type of combination cancer therapy that’s less toxic than standard treatments.
Bloomberg
Bloomberg
Upcoming Events
-
07May
-
14May
-
30May